Fairvoy Private Wealth
ABBV icon

Fairvoy Private Wealth’s AbbVie ABBV Stock Holding History

Fairvoy Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$643K Buy
2,459
+462
+23% +$118K 0.13% 122
2026
Q2 		$503K Hold
1,997
– – 0.1% 139
2026
Q1 		$434K Hold
1,997
– – 0.1% 146
2025
Q4 		$456K Sell
1,997
-20
-1% -$4.56K 0.1% 126
2025
Q3 		$467K Sell
2,017
-110
-5% -$22.4K 0.11% 125
2025
Q2 		$395K Buy
2,127
+170
+9% +$31.6K 0.1% 129
2025
Q1 		$410K Sell
1,957
-4
-0.2% -$778 0.11% 126
2024
Q4 		$348K Buy
+1,961
New +$361K 0.09% 135

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Fairvoy Private Wealth's ABBV Position: Q3 2026 in Review

Fairvoy Private Wealth increased its AbbVie (ABBV) stake by 23% in Q3 2026, buying an estimated $118K and bringing the position to 2,459 shares worth $643K. The position accounts for 0.13% of the portfolio, ranked #122.

Fairvoy Private Wealth first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. 1,925 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Fairvoy Private Wealth held 2,459 shares of AbbVie worth $643K as of Q3 2026.
  • Fairvoy Private Wealth bought 462 AbbVie shares in Q3 2026, an estimated $118K.
  • AbbVie made up 0.13% of Fairvoy Private Wealth's portfolio in Q3 2026, its #122 holding.
  • Fairvoy Private Wealth first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • 1,925 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Fairvoy Private Wealth's 13F filing for Q3 2026, filed 19 Oct 2026.